2022
DOI: 10.1111/febs.16649
|View full text |Cite
|
Sign up to set email alerts
|

Senescent cells in the brain and where to find them

Abstract: Cellular senescence is a process in which cells change their characteristic phenotype in response to stress and enter a state of prolonged cell cycle arrest accompanied by a distinct secretory phenotype. Cellular senescence has both beneficial and detrimental outcomes. With age, senescent cells progressively accumulate in tissues and might be the bridge connecting ageing to many age‐related pathologies. In recent years, evidence emerged supporting the accumulation of brain senescent cells during neurological d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 115 publications
0
8
0
Order By: Relevance
“…Cellular senescence is a process in which cells change their characteristic phenotype in response to stress and enter a state of prolonged cell cycle arrest accompanied by a distinctive secretory phenotype which can alter the tissue microenvironment and contribute to inflammation, oxidative stress, and tissue dysfunction ( Tchkonia et al, 2013 ; Rachmian and Krizhanovsky, 2022 ). It is known that senescent cells accumulate during obesity ( Minamino et al, 2009 ; Ogrodnik et al, 2017 ; Schafer et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Cellular senescence is a process in which cells change their characteristic phenotype in response to stress and enter a state of prolonged cell cycle arrest accompanied by a distinctive secretory phenotype which can alter the tissue microenvironment and contribute to inflammation, oxidative stress, and tissue dysfunction ( Tchkonia et al, 2013 ; Rachmian and Krizhanovsky, 2022 ). It is known that senescent cells accumulate during obesity ( Minamino et al, 2009 ; Ogrodnik et al, 2017 ; Schafer et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…This study suggests that targeting senescent cells may open new potential therapeutic strategies for AD, which might be effective even at late-disease stages. However, the senolytic drugs available today have limited applicability to humans due to their side effects 10,42 . In the future, developing new senolytic therapies that exclusively target senescent cells, or specifically, senescent microglia should be considered.…”
Section: Discussionmentioning
confidence: 99%
“…As a consequence, SnCs from different tissues exhibit variations in both the composition and function of the SASP, and in the clearance process (Hernandez‐Segura et al., 2017 ; Ritschka et al., 2017 ; Storer et al., 2013 ; Victorelli et al., 2019 ). This observation may have clinical implications since different cell types from the same organ can undergo senescence, such as in kidneys (where senescence has been noted in tubular epithelial cells, endothelial cells, mesangial cells, and podocytes; Huang et al., 2022 ), liver (with reported senescence in hepatocytes, stellate cells, and cholangiocytes; Aravinthan & Alexander, 2016 ), lungs (with observed senescence in fibroblasts, epithelial cells, and endothelial cells) (Hansel et al., 2020 ), and brain (in which both glia and neurons can undergo senescence; Rachmian & Krizhanovsky, 2023 ). Therefore, given that the phenotype of SnCs from different tissues can differ within the same organ, a significant challenge in the field is to mitigate the detrimental effects of SnCs while preserving their beneficial roles.…”
Section: Heterogeneities Plasticity and Dynamics Of Cellular Senescencementioning
confidence: 99%